ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 71.80
+10.80 (17.70%)
Jul 23, 2025, 10:59 AM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 3.73 billion as of July 22, 2025. Its market cap has increased by 105.39% in one year.
Market Cap
3.73B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
71.80
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 3.73B, an increase of 170.58%. That is a compound annual growth rate of 28.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2025 | 4.28B | 173.58% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 207.06B |
| PharmaEssentia | 181.63B |
| Bora Pharmaceuticals Co., LTD. | 86.16B |
| Lotus Pharmaceutical | 58.37B |
| Oneness Biotech | 31.42B |
| Polaris Group | 30.05B |
| Center Laboratories | 26.92B |
| TaiMed Biologics | 23.62B |